$VXRT Part 2/3: Looks like Biden’s Cabinet position leader focused on pandemic preparedness believes in the importance of a broadly cross-reactive Covid vaccine to fight multiple variants and even the common cold. Vaxart has been focused on this and has put out a few press releases and news articles talking-up their S+N Covid vaccine’s cross-reactivity and ability to fight some of the a coronavirus strains that cause the common cold. Looks like Eric Lander might want to invest in Vaxart’s “Universal Covid Vaccine”. Looks like he might even know about their research given his comments about the common cold (so far I recall only the US Army vaccine team and Vaxart have put out PR and news about their vaccine’s potential ability to fight Coronaviruses that cause the common cold). His comments in the below excerpt about the common cold are VERY interesting!
17
17 Likes